Oaktree Acquisition Corp. III Life Sciences (OACC) is a Shell Companies company in the Financial Services sector, currently trading at $10.68. It has a SharesGrow Score of 61/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of OACC = $20.22 (+89.3% from the current price, the stock appears undervalued).
Valuation: OACC trades at a trailing Price-to-Earnings (P/E) of 35.7 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 5.
Net income is $7M, growing at +273607.2%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).
Balance sheet: total debt is $11,824 against $195M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 1.19 (adequate). Debt-to-assets is 0%. Total assets: $203M.
SharesGrow 7-Criteria breakdown: Value 18/100 (Fail), Growth 100/100 (Pass), Past 100/100 (Pass), Health 75/100 (Pass), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).